Navigation Links
Avastin May Help Boost Survival With Aggressive Cervical Cancer: Study
Date:2/8/2013

FRIDAY, Feb. 8 (HealthDay News) -- The cancer drug Avastin may extend the lives of patients with aggressive cervical cancer, a new study finds.

The findings might change the way these patients are treated and improve outcomes for women "who have previously had very limited treatment options," study lead researcher Dr. Krishnansu Tewari, said in a news release from the U.S. National Cancer Institute (NCI).

The research was sponsored by the NCI and received support from Genentech Inc., which makes Avastin.

The study included 452 women with recurrent, advanced or persistent cervical cancer that was not curable with standard chemotherapy. Patients who received Avastin with their chemotherapy lived an average of 17 months, compared with just over 13 months for those treated with chemotherapy alone, the investigators found.

The patients who received Avastin were given a dose of 15 milligrams per kilogram of body weight, which was administered in the vein with their chemotherapy treatment. The dose was given one day every three weeks until the patient's cancer progressed or levels of the drug in the body became too high.

Patients who received Avastin did have more side effects than those who didn't take the drug, the researchers noted, and the side effects were consistent with those known to be associated with Avastin -- events such as bleeding, clotting and gastrointestinal issues.

Avastin also comes with a hefty price tag, about $5,000 per month.

Still, the increase in survival seen with Avastin "is welcome news as progress has been very difficult against this cancer," Dr. Jeff Abrams, clinical director of NCI's Division of Cancer Treatment and Diagnosis, said in the news release.

Another expert not connected to the study agreed.

Dr. Elizabeth Poynor, a gynecologic oncologist and pelvic surgeon at Lenox Hill Hospital in New York City, noted that women with advanced cervical cancers that pro
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. FDA Issues Another Warning on Fake Version of Cancer Drug Avastin
2. Avastin Shows No Benefit for Earlier Colon Cancer: Study
3. Avastin Wont Extend Breast Cancer Survival: Study
4. Interpreting the Avastin-Lucentis study for persons with macular degeneration
5. Avastin No Benefit to Older Lung Cancer Patients: Study
6. More Fake Avastin Found in U.S., FDA Says
7. A Good Mood May Boost Seniors Brain Power
8. Living Near Equator May Boost Your Risk for Allergy, Asthma
9. Personalized plans to address barriers to HIV drug adherence boost chances of successful therapy
10. Fried Foods May Boost Prostate Cancer Risk, Study Says
11. Plastic Surgery Practice Gets Boost from Lower Eyelid Surgery Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Avastin May Help Boost Survival With Aggressive Cervical Cancer: Study
(Date:9/2/2014)... might be a new salve to dominate medicine cabinets of ... salamander. Salamanders may not be the cuddliest of animals, but ... seriously damaged body parts. Now, a new report published in ... , identifies a small protein (called a "peptide") from ... unlocking the secret of this amazing wound healing trick in ...
(Date:9/2/2014)... clear that a mother,s eating habits prior to pregnancy, ... on her offspring and their propensity for developing weight ... behind this phenomenon were unclear. According to new research ... The FASEB Journal F , scientists using an animal ... and an offspring,s risk of future obesity. This link ...
(Date:9/2/2014)... September 02, 2014 Concorde Career ... chosen to receive the 2014 Excellence in Community ... Schools and Colleges (ACCSC). , Every year, the ... community members who make outstanding contributions in their ... evaluated for the scope and impact of the ...
(Date:9/2/2014)... research involving mice suggests that the key to more ... cabinet. In a report published in the ... macrophages from the lungs of old mice had different ... young mice, but these changes were reversed by ibuprofen. ... on immune function," said Joanne Turner, Ph.D., a researcher ...
(Date:9/2/2014)... Splashtop Inc. , the worldwide leader ... NTT DoCoMo to deliver Splashtop Business Lite for ... is included in NTT DoCoMo’s “Business Plus” program. , ... empower users to remote access their corporate computers from ... million users worldwide. Splashtop delivers the best in ...
Breaking Medicine News(10 mins):Health News:Salamander skin peptide promotes quick and effective wound healing in mice 2Health News:How genes link a mother's diet to the risk of obesity in her offspring 2Health News:Concorde Career College North Hollywood Awarded 2014 Excellence in Community Service Award 2Health News:Splashtop and NTT DoCoMo Partner to Deliver “Splashtop Business Lite” Secure Remote Access Solution to Business Customers 2
... CHICAGO, July 28 Underscoring the need for meaningful health ... is running an ad today emphasizing common ground on health reform to ... ad runs nationally today in the Chicago Tribune , New ... will run in various medical trade publications. , ...
... , , NEW ORLEANS, ... with eye and vision problems across the United States, Louisiana ... assessments for infants between six to 12 months of age ... Charity(TM) - The AOA Foundation in partnership with The Vision ...
... MADISON, Wis., July 28 In today,s health environment, harmful ... risk to young children. And, at the same time, the FDA ... children under the age of four. Parents of young children are ... and healthy. Many are embracing preventative measures to improve their child,s ...
... , , , ... York State Department of Transportation announced that today, July 28, 2009, ... will be unhealthy, especially for sensitive individuals, such as children, seniors ... high levels of ground-level ozone pollution. The alert is issued for ...
... YORK, July 28 The National Center on Addiction and Substance Abuse ... elected to its board of directors. , , (Logo: ... Tuggle is senior vice president of Global Public Affairs and Communications at ... held a variety of positions in the U.S. and abroad where he ...
... , , , ... (OTC Bulletin Board: TCSR), which develops, manages and owns faith-based senior ... Deutsche Bank Berkshire Mortgage, Inc. for the development of a new ... Heights , an 82-unit, $10 million senior ...
Cached Medicine News:Health News:New AMA Ad Emphasizes Common Ground on Health Reform, Shares Vision to Fix Broken System 2Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 2Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 3Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 4Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 5Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 6Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 7Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 8Health News:HOWARU(R) Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 2Health News:Air Quality Action Day Declared for Today, July 28, 2009 2Health News:Clyde C. Tuggle, Senior Vice President at The Coca-Cola Company, Elected to CASA* Board 2Health News:Clyde C. Tuggle, Senior Vice President at The Coca-Cola Company, Elected to CASA* Board 3Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 2Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 3Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 4
(Date:9/2/2014)... Sept. 2, 2014  Abaxis, Inc. (NasdaqGS: ... instrumentation and consumables to the medical, research and veterinary ... and Chief Executive Officer, will present at the Morgan ... at 10:20 a.m. ET. The conference will be held ... New York City . About Abaxis ...
(Date:9/2/2014)...  Hologic, Inc. (NASDAQ: HOLX ) today announced ... will present at the Morgan Stanley Global Healthcare Conference in ... York on Tuesday, September 9, 2014 at 12:20 ... listen to the live audio webcast of the presentation on ... An archive of the presentation will be available for replay ...
(Date:9/2/2014)... SAN DIEGO , Sept. 2, 2014  Arena ... that the US Food and Drug Administration (FDA) has ... of pulmonary arterial hypertension. "The FDA ... clinical data submissions from sponsors to identify and designate ... help advance the evaluation and development of such products," ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 4
... ARLINGTON HEIGHTS, Ill., Sept. 12 Even as,many ... available today,we are stopped by our rear reflection and ... study published in the October issue of Plastic and,Reconstructive ... Plastic Surgeons (ASPS), reveals a new back lift procedure ...
... Ala., Sept. 11 - Southern,Research Institute and ... from a study testing Naltrexone-derived,pyridomorphinan (SoRI-9409) will ... of,the journal Biological Psychiatry. The publication is ... suggests that a new compound that,causes selective ...
Cached Medicine Technology:Say 'Goodbye' to Back Fat Rolls 2Novel Compound Shows Promise for Treatment of Alcoholism 2Novel Compound Shows Promise for Treatment of Alcoholism 3Novel Compound Shows Promise for Treatment of Alcoholism 4
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
The Ultra HDL (UHDL) assay is used for the quantitation of high density lipoprotein (HDL) cholesterol in human serum or plasma....
... A histological embedment block ... This file system incorporates ... embedment block protection, simplified ... error and facilitation of ...
... The first instrumentation ... efficiently manage the ... Proven technology automatically ... collates cassettes sequentially. ...
Medicine Products: